Anti-oxidant and Hepatoprotective Possibilities of Lycopene against Monosodium Glutamate Induced Detrimental Effects in Rats
Elwan, S., Bahr, H., Hassan, A., El Ghannam, A., Mahmoud, Y. (2021). Anti-oxidant and Hepatoprotective Possibilities of Lycopene against Monosodium Glutamate Induced Detrimental Effects in Rats. EKB Journal Management System, 26(2), 341-354. doi: 10.21608/scvmj.2021.217936
Shawkie Elwan; Hoda Bahr; Abeer Hassan; Abd El Rehim El Ghannam; Yasmina Mahmoud. "Anti-oxidant and Hepatoprotective Possibilities of Lycopene against Monosodium Glutamate Induced Detrimental Effects in Rats". EKB Journal Management System, 26, 2, 2021, 341-354. doi: 10.21608/scvmj.2021.217936
Elwan, S., Bahr, H., Hassan, A., El Ghannam, A., Mahmoud, Y. (2021). 'Anti-oxidant and Hepatoprotective Possibilities of Lycopene against Monosodium Glutamate Induced Detrimental Effects in Rats', EKB Journal Management System, 26(2), pp. 341-354. doi: 10.21608/scvmj.2021.217936
Elwan, S., Bahr, H., Hassan, A., El Ghannam, A., Mahmoud, Y. Anti-oxidant and Hepatoprotective Possibilities of Lycopene against Monosodium Glutamate Induced Detrimental Effects in Rats. EKB Journal Management System, 2021; 26(2): 341-354. doi: 10.21608/scvmj.2021.217936

Anti-oxidant and Hepatoprotective Possibilities of Lycopene against Monosodium Glutamate Induced Detrimental Effects in Rats

Suez Canal Veterinary Medical Journal. SCVMJ
Article 7, Volume 26, Issue 2, December 2021, Page 341-354  XML
Document Type: Original Article
DOI: 10.21608/scvmj.2021.217936
View on SCiNiTO View on SCiNiTO
Authors
Shawkie Elwan email 1; Hoda Bahr2; Abeer Hassan2; Abd El Rehim El Ghannam2; Yasmina Mahmoud2
1Veterinarian
2Department of Biochemistry, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt
Abstract
The present experiment aimed to investigate anti-oxidant and hepatoprotective possibilities of lycopene (LYC) versus hepatic biochemical alterations induced by administration of monosodium glutamate (MSG). Rats were classified into five groups; Group I- (control), Group II- (MSG  15 mg/kg ), Group III- (MSG 35 mg/kg), Group IV- (MSG 15 mg/kg + LYC), Group V- (MSG 35 mg/kg + LYC). Our results demonstrated that MSG administration at both doses (15, 35 mg/kg /day) for 30 days induced hepatic toxicity as indicated with elevated hepatic enzyme leakage, oxidative stress, and hepatic histopathological deterioration comparing to control group. On the contrary, supplementation of LYC (10 mg/kg /day) pre- MSG administration for 10 days and co-administration with MSG for 30 days partially restored hepatic enzymes and elevated the anti-oxidant enzyme activities via reducing hepatic enzymes alanine aminotransferase (ALT), aspartate aminotransferase (AST) and increasing superoxide dismutase (SOD), glutathione peroxidase (GPx) activities, reduced glutathione (GSH) level, in line with decreased malondialdehyde (MDA), and transforming growth factor beta1 (TGF-β1). As well as, lycopene administration improved hepatic architecture comparing to MSG. Taken together, the present results summarize that lycopene administration showed hepatoprotective effects versus monosodium glutamate promoted hepatic toxicity and thus can be considered as a novel hepatoprotective medication in clinic after being valid
Keywords
Monosodium glutamate; Lycopene; Liver; Oxidative stress; Rats
Supplementary Files
Statistics
Article View: 160